Slávka Baróniková shares her opinions on open access publishing and suggests how this can be successfully achieved within pharma.
The Research Data Alliance has published standardised research data policies, but wider collaboration is needed to ensure they are supported and implemented.
A recent article in Nature reveals how dedicated data sharing infrastructure may be key to facilitating systematic research into peer review processes.
The latest State of Open Data survey results show changing trends in researchers’ attitudes towards the use of open data.
With widespread and growing support for increased data sharing, what can we learn from the Yale Open Data Access (YODA) Project and its collaboration with Johnson & Johnson?
UNESCO uses this year’s World Science Day for Peace and Development to examine global disparities in open science.
An analysis of data sharing statements reveals that open data may lead to a citation advantage.
Discover the five areas for improvement identified in Springer Nature’s recent surveys of researchers, aiming to promote data sharing.
Discover how to track the proliferation of initiatives aimed at improving the peer review process.
Are you familiar with the FAIR data principles? Find out how to boost your data’s usefulness by making your data FAIR: Findable, Accessible, Interoperable, and Reusable.
AllTrials seeks support for a new initiative to monitor clinical trial reporting in the UK.
Transparency and reproducibility are now synonymous with medical publications, but actions speak louder than words. A recent study examines whether progress has been made.
Missed ISMPP EU 2019? Read our meeting report to get up to speed!
Increasing quality and transparency of preclinical data: an opportunity for publication professionals?
An article in the MAP newsletter examines how publication professionals could help to increase preclinical publishing standards.
Researchers can win Wellcome Data Re-use Prizes for new insights, tools or health applications generated from re-use of open data.
A number of initiatives developed to prevent researchers from only reporting the most impressive outcomes of clinical trials are explored in an opinion piece from The BMJ.